News

EMVO has been working to manage the implications of Brexit (the UK’s departure from the EU Internal Market rules) for the EMVS and its users.

A new version of the European Commission’s Questions & Answers document on “Safety Features for Medicinal Products for Human Use (V.18)” is available from August 11.

Document published by the European Commission

Newsletter includes general news update and technical updates.

European Medicines Verification Organization (EMVO) on September 27 has published the latest EMVO Newsletter.